Suven Life Sciences Limited (NSE:SUVEN)
India · Delayed Price · Currency is INR 265.99
-3.53 (-1.31%)
May 22, 2026, 3:29 PM IST
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 70.15 billion as of May 22, 2026. Its market cap has increased by 145.46% in one year.
Market Cap
70.15B
Enterprise Value
65.14B
Revenue
210.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
265.99
Market Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 70.15B, an increase of 4,253.07%. That is a compound annual growth rate of 17.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 70.15B | 84.83% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cohance Lifesciences | 160.12B |
| Alembic Pharmaceuticals | 148.54B |
| Alivus Life Sciences | 127.52B |
| Strides Pharma Science | 106.29B |
| Akums Drugs and Pharmaceuticals | 79.62B |
| Sudeep Pharma | 76.05B |
| Sun Pharma Advanced Research Company | 68.07B |
| Aarti Pharmalabs | 64.65B |